NEW YORK (GenomeWeb News) – Investment bank Thomas Weisel Partners has increased its fourth-quarter and full-year 2009 revenue guidance for Affymetrix, two weeks before the firm is scheduled to report its results.

Analyst Peter Lawson said that the bank has increased its Q4 estimate to $83 million from its previous estimate of $82 million, slightly above analysts' consensus estimate of $82.8 million. It also lowered the firm's loss per share to $.10 from $.11, in line with the consensus estimate.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

Oct
17
Sponsored by
Lexogen

This webinar will present a method for RNA-seq expression analysis of FFPE-derived RNA samples that are too degraded for successful application of standard RNA-seq techniques.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.